Bidirectional communication between the neuroendocrine system and the immune system: Relevance to health and diseases

Annals of Neurosciences

Volumn 19, Issue 1, 2012, Pages 40-46

  ThyagaRajan, Srinivasan ^a   Priyanka, Hannah P ^a  

^a SRM INSTITUTE OF SCIENCE AND TECHNOLOGY   (India)

Author keywords

Brain; Cytokine; Hormone; Lymphoid organs; Neurotransmitter

Indexed keywords

CYTOKINE; GROWTH FACTOR; NEUROPEPTIDE; NEUROTRANSMITTER;

BLOOD BRAIN BARRIER; BONE MARROW; CENTRAL NERVOUS SYSTEM; CYTOKINE RELEASE; DEGENERATIVE DISEASE; DISEASE COURSE; HEALTH CARE; HORMONE RELEASE; HUMAN; HYPOPHYSIS; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; IMMUNE SYSTEM; INFECTION SENSITIVITY; LIMBIC CORTEX; LYMPH NODE; LYMPHOID ORGAN; LYMPHOID TISSUE; NEUROENDOCRINE SYSTEM; NEUROTRANSMITTER RELEASE; NORADRENERGIC SYSTEM; PATHOGENESIS; PEPTIDERGIC NERVOUS SYSTEM; REVIEW; SPLEEN; SYMPATHETIC INNERVATION; THYMUS;

EID: 84861983691     PISSN: 09727531     EISSN: 09763260     Source Type: Journal    
DOI: 10.5214/ans.0972.7531.180410     Document Type: Review

References (49)

1. Besedovsky HO and del Rey A. Physiological implications of the immuno-neuro-endocrine network. In: Ader R, Cohen N, Felten DL Eds. Psychoneuroimmunology. 2nd ed. New York: Academic Press 1991; 589-608.
2. Dinarello CA. IL-1: discoveries, controversies and future directions. Eur J Immunol. 2010; 40(3): 599-606.
3. Banks WA, Kastin AJ and Broadwell RD. Passage of cytokines across the blood-brain barrier. Neuroimmunomodulation. 1995; 2(4): 241-248.
4. Dunn A. Systemic interleukin-1 administration stimulates hypothalamic norepinephrine metabolism paralleling the increased plasma corticosterone. Life Science 1988; 43: 429-435.
5. Mohan Kumar PS, ThyagaRajan S and Quadri SK. Interleukin-1 stimulates the release of dopamine and dihydroxyphenylacetic acid from the hypothalamus in vivo. Life Science 1991; 48: 925-930.
6. Breder CD, Dinarello CA, Saper CB. Interleukin- 1 immunoreactive innervation of the human hypothalamus. Science.1988; 240 (4850): 321-324.
7. Spangelo BL, Gorospe WC. Role of the cytokines in the neuroendocrine-immune system axis. Front Neuroendocrinol. 1995; 16(1): 1-22.
8. Dantzer R. Cytokine, sickness behavior, and depression. Immunol Allergy Clin North Am. 2009; 29(2): 247-264.
9. Thayer JF, Sternberg EM. Neural aspects of immunomodulation: focus on the vagus nerve. Brain Behav Immun. 2010; 24(8): 1223-1228.
10. Ader R. Conditioned immunomodulation: Research needs and directions. Brain Behav Immun. 2003; 17: S51-S57.
11. Quan N, Herkenham M. Connecting cytokines and brain: a review of current issues. Histol Histopathol. 2002; 17(1): 273-288.
12. Yong VW, Rivest S. Taking advantage of the systemic immune system to cure brain diseases. Neuron 2009; 64(1): 55-60.
13. Bernardes-Silva M, Anthony DC, Issekutz AC, et al. Recruitment of neutrophils across the blood-brain barrier: the role of Eand P-selectins. J Cereb Blood Flow Metab. 2001; 21(9): 1115-1124.
14. Del Maschio A, Zanetti A, Corada M., et al. Polymorphonuclear leukocyte adhesion triggers the disorganization of endothelial cell-to-cell adherens junctions. J Cell Biol. 1996; 135(2): 497-510.
15. Denes A, Thornton P, Rothwell NJ, et al. Inflammation and brain injury: acute cerebral ischaemia, peripheral and central inflammation. Brain Behav Immun. 2010; 24(5): 708-723.
16. Ren K, Dubner R. Interactions between the immune and nervous systems in pain. Nat Med. 2010; 16(11): 1267-1276.
17. Felten DL, Felten SY, Carlson SL, et al. Noradrenergic and peptidergic innervation of lymphoid tissue. Journal of Immunology 1985; 135: 755s-765s.
18. Bellinger DL, Lorton D, Lubahn C, et al. Innervation of lymphoid organs-Association of nerves with cells of the immune system and their implications in disease. In: Ader R., Felten DL, Cohen N. Eds., Psychoneuroimmunology. Vol. 1. San Diego: Academic Press, 2001; 5-111.
19. Bellinger DL, Madden KS, Lorton D, et al. Agerelated alterations in neural-immune interactions and neural strategies in immunosenescence. In: Ader R., Felten DL, Cohen N. Eds., Psychoneuroimmunology. Vol. 1. San Diego: Academic Press, 2001: 241-288.
20. Madden KS. Catecholamines, sympathetic innervation, and immunity. Brain Behav Immun. 2003; 17 Suppl1: S5-S10.
21. Thyagarajan S and Felten DL. Modulation of neuroendocrine-immune signaling by Ldeprenyl and L-desmethyldeprenyl in aging and mammary cancer. Mechanisms of Ageing and Development 2002; 123: 1065-1079.
22. Tabarowski Z, Gibson-Berry K and Felten SY. Noradrenergic and peptidergic innervation of the mouse femur bone marrow, Acta Histochemica. 1996;98: 453-457.
23. Maestroni GJ and Conti A. Modulation of hematopoiesis via alpha 1-adrenergic receptors on bone marrow cells, Experimental Hematology 1994; 22: 313-320.
24. Yamazaki K and Allen TD. Ultrastructural morphometric study of efferent nerve terminals on murine bone marrow stromal cells, and the recognition of a novel anatomical unit: the "neuro-reticular complex. American Journal of Anatomy 1990; 187: 261-276.
25. Nance DM, Hopkins DA and Bieger D. Re-investigation of the innervation of the thymus gland in mice and rats. Brain Behav Immun. 1987; 1: 134-147.
26. Singh U and Owen JJT. Studies on the maturation of thymus stem cells. The effects of catecholamines, histamine, and peptide hormones on the expression of T allo-antigens. European Journal of Immunology 1976; 6: 59-62.
27. Giron LTJ, Crutcher KA and Davis JN. Lymph nodes-a possible site for sympathetic neuronal regulation of immune responses. Annals of Neurology 1980; 8: 520-525.
28. Kin NW, Sanders VM. It takes nerve to tell T and B cells what to do. J Leukoc Biol. 2006; 79(6): 1093-1104.
29. Nance DM, Sanders VM. Autonomic innervation and regulation of the immune system (1987-2007). Brain Behav Immun. 2007; 21(6):736-745.
30. Sanders VM. Epigenetic regulation of Th1 and Th2 cell development. Brain Behav Immun. 2006; 20(4): 317-324.
31. Kouassi E, Li YS, Boukhris W, et al. Opposite effects of the catecholamines dopamine and norepinephrine on murine polyclonal B-cell activation. Immunopharmacology 1988; 16: 125-137.
32. Kruszewska B, Felten SY, Moynihan JA. Alterations in cytokine and antibody production following chemical sympathectomy in two strains of mice. Journal of Immunology 1995; 155: 4613-4620.
33. Blalock JE. Shared ligands and receptors as a molecular mechanism for communication between the immune and neuroendocrine systems. Annals of New York Academcy of Sciences. 1994; 741: 292-298.
34. Engler KL, Rudd ML, Ryan JJ, et al. Autocrine actions of macrophage-derived catecholamines on interleukin-1 beta. J Neuroimmunol. 2005; 160(1-2): 87-91.
35. Schulte-Herbrüggen O, Nassenstein C, Lommatzsch M, et al. Tumor necrosis factor-a and interleukin-6 regulates secretion of brain-derived neurotrophic factor in human monocytes. J Neuroimmunol. 2005; 160: 204-209.
36. Cole SW, Korin YD, Fahey JL., et al. Norepinephrine accelerates HIV replication via protein kinase A-dependent effects on cytokine production. J Neuroimmunol. 1998; 161: 610-616.
37. Haraguchi S, Good RA, James-Yarish M, et al. Induction of intracellular cAMP by a synthetic retroviral circulation following envelope peptide: a possible mechanism of immunopathogenesis in retroviral infections, Proceedings of National Academy of Sciences USA 1995; 92: 5568-5571.
38. Kelley SP, Moynihan JA, Stevens SY, et al. Sympathetic nerve destruction in spleen in murine AIDS. Brain Behav Immun. 2003; 17(2): 94-109.
39. Kelley SP, Moynihan JA, Stevens SY, et al. Chemical sympathectomy has no effect on the severity of murine AIDS: murine AIDS alone depletes norepinephrine levels in infected spleen. Brain Behav Immun. 2002; 16(2): 118-139.
40. Wieseler-Frank J, Jekich BM, Mahoney JH, et al. A novel immune-to-CNS communication pathway: cells of the meninges surrounding the spinal cord CSF space produce proinflammatory cytokines in response to an inflammatory stimulus. Brain Behav Immun. 2007; 21(5): 711-718.
41. Kaul M, Lipton SA. Mechanisms of neuronal injury and death in HIV-1 associated dementia. Curr HIV Res. 2006; 4:307-318.
42. Evans SR, Yeh TM, Sacktor N, et al. Selegiline transdermal system (STS) for HIV-associated cognitive impairment: open-label report of ACTG 5090. HIV Clinical Trials 2007; 8: 437-446.
43. Schifitto G, Zhang J, Evans SR, et al. A multicenter trial of selegiline transdermal system for HIV-associated cognitive impairment. Neurology 2007; 69: 1314-1321.
44. Sohrabji F, Lewis DK. Estrogen-BDNF interactions: implications for neurodegenerative diseases. Front Neuroendocrinol. 2006; 27(4): 404-414.
45. Romeo HE, Colombo LL, Esquifino AI, et al. Slower growth of tumours in sympathetically denervated murine skin. J Auton Nerv Syst. 1991; 32(2): 159-164.
46. Brenner GJ, Felten SY, Felten DL, et al. Sympathetic nervous system modulation of tumor metastases and host defense mechanisms. J Neuroimmunol. 1992; 37(3):191-201.
47. Ben-Eliyahu S, Page GG, Schleifer SJ. Stress, NK cells, and cancer: Still a promissory note. Brain Behav Immun. 2007; 21(7): 881-887.
48. McEwen BS, Gianaros PJ. Central role of the brain in stress and adaptation: links to socioeconomic status, health, and disease. Ann N Y Acad Sci. 2010; 1186: 190-222.
49. Kiecolt-Glaser JK, Gouin JP, Hantsoo L. Close relationships, inflammation, and health. Neurosci Biobehav Rev. 2010; 35(1): 33-38.